Tiziana to Participate in January Investor Meetings
New York, Dec. 16, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq:TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough CNS immunomodulation approaches to enhance the functionality of Treg-based therapies, announced today that the Company plans to present at the Biotech Showcase and host institutional investor and partnering meetings at this event, as well as at the LifeSci Corporate Access Event. Both in-person events are taking place January 9-10, 2023 in San Francisco, California.
Related news for (TLSA)
- MoBot’s Stock Market Highlights – 07/30/25 04:00 PM
- 24/7 Market News Snapshot 23 May, 2025 – Tiziana Life Sciences Ltd. Common Shares (NASDAQ:TLSA)
- Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
- Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer’s Patient Treated with Intranasal Foralumab
- Breaking News: MoBot’s Latest Update as of 05/06/25 02:00 PM